Beijing Tiantan Biological Products Co., Ltd. (SHA:600161)
China flag China · Delayed Price · Currency is CNY
12.02
-0.11 (-0.91%)
Nov 17, 2026, 3:00 PM CST

SHA:600161 Revenue

Beijing Tiantan Biological Products had revenue of 1.26B CNY in the quarter ending September 30, 2026, a decrease of -7.23%. This brings the company's total for the last twelve months to 5.56B, down -13.52% year-over-year. In the year 2025, Beijing Tiantan Biological Products had annual revenue of 6.17B with 2.26% growth. That makes Beijing Tiantan Biological Products the 8,520th largest company in the world by revenue and 1,307th in China.

Revenue (ttm)
5.56B
Revenue Growth
-13.52%
P/S Ratio
4.28
Revenue / Employee
1.07M
Employees
5,205
Market Cap
23.77B

Revenue Chart

Revenue by Geography

  • China 6.15B 100.0%
  • Overseas 1.62M 0.0%
Fiscal year ended Dec 31, 2025 See the full SHA:600161 breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20256.17B136.17M2.26%
Dec 31, 20246.03B851.42M16.44%
Dec 31, 20235.18B919.14M21.57%
Dec 31, 20224.26B149.15M3.63%
Dec 31, 20214.11B666.56M19.35%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.